Tinnitus, Subjective: Clinical Trials

2 trials for Tinnitus, Subjective, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Completed 2
Phase 21Completed 1

Follow Tinnitus, Subjective: new trials by email Literature Review of Tinnitus, Subjective trials Research Report on Tinnitus, Subjective

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Treatment of Tinnitus With Olanzapine
Olanzapine 5 Mg ORAL TABLET, Placebo Drug - Tinnitus, Tinnitus, Subjective
Phase 1CompletedUniversity of Sao Paulo502023-10-012026-09-15
OTO-313 in Subjects With Subjective Tinnitus
OTO-313, Placebo - Tinnitus, Subjective
Phase 1 / Phase 2CompletedOtonomy, Inc.432019-04-042022-12-23

Narrower conditions

Tinnitus (2)

Broader conditions

Ear Diseases (2)  ·  Hearing Disorders (2)  ·  Nervous System Diseases (2)  ·  Neurologic Manifestations (2)  ·  Otorhinolaryngologic Diseases (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Sensation Disorders (2)  ·  Signs and Symptoms (2)

Interventions

Olanzapine (1)  ·  Tablets (1)

Sponsors

Otonomy, Inc. (1)  ·  University of Sao Paulo (1)

Countries

Brazil (1)  ·  United States (1)